M
Marco Matucci Cerinic
Researcher at University of Florence
Publications - 147
Citations - 4772
Marco Matucci Cerinic is an academic researcher from University of Florence. The author has contributed to research in topics: Medicine & Interstitial lung disease. The author has an hindex of 36, co-authored 133 publications receiving 4125 citations. Previous affiliations of Marco Matucci Cerinic include University of Cagliari & Vita-Salute San Raffaele University.
Papers
More filters
Journal ArticleDOI
Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases
Yehuda Shoenfeld,Roberto Gerli,Andrea Doria,Eiji Matsuura,Marco Matucci Cerinic,Nicoletta Ronda,Luis J. Jara,Mahmud Abu-Shakra,Pier Luigi Meroni,Yaniv Sherer,Yaniv Sherer +10 more
TL;DR: Several AIRDs exhibit increased overt cardiovascular disease (CVD) prevalence as well as findings of advanced subclinical atherosclerosis, which may precede the appearance of a clinical disease and thus be a target of early identification and preventive therapy.
Journal ArticleDOI
Raynaud's phenomenon and the role of capillaroscopy
Journal ArticleDOI
The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis†‡
Francesco Zulian,Patricia Woo,Balu H. Athreya,Ronald M. Laxer,Thomas A. Medsger,Thomas J. A. Lehman,Marco Matucci Cerinic,Giorgia Martini,Angelo Ravelli,Ricardo Russo,Ruben Cuttica,Sheila Knupp Feitosa de Oliveira,Christopher P. Denton,Franco Cozzi,Ivan Foeldvari,Nicolino Ruperto +15 more
TL;DR: These provisional classification criteria for juvenile SSc will help standardize the conduct of clinical research, epidemiologic and outcome studies, and therapeutic trials.
Journal ArticleDOI
Vascular complications of scleroderma
TL;DR: Almost all patients with systemic sclerosis develop Raynaud's phenomenon which, together with structural vasculopathy, results in ulceration and critical digital ischemia, and management of digital ulcers includes non-pharmacologic and pharmacologic modalities.
Journal ArticleDOI
Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis
Tatiana Barskova,Luna Gargani,Serena Guiducci,Silvia Bellando Randone,Cosimo Bruni,G. Carnesecchi,Maria Letizia Conforti,Francesco Porta,Alberto Moggi Pignone,Davide Caramella,Eugenio Picano,Marco Matucci Cerinic +11 more
TL;DR: The use of LUS as a screening tool for ILD may be feasible to guide further investigation with HRCT, and the presence of B-lines at LUS examination correlates with ILD at HRCT.